#Dr. Vasan S S

[localnewspaper-blog]

WOW WOMEN

WOW #WOMEN Chief Guests Actress #PoornimaBhagyaraj and #Actress #GayatriRavi gave away the prizes to the winners of the various contests. #News #Events #Chennai

WOW WOMEN 2023.  VIRGO EVENTS celebrated SIMS HOSPITAL WOW WOMEN 2023  – a Women’s day gala at Hotel Ramada Plaza on the 11th of March. The Highlight of the event was a Panel Discussion by SHE CLINIC doctors-  Dr. K R Sharmatha, Consultant – Aesthetic Dermatology | Dr. Sandhya Vasan, Senior Consultant – Obstetrics & Gynaecology & IVF | Dr. N S Saradha Senior Consultant – Obstetrics, Gynaecology &…

[reogenindia]

M S Child Care Clinic | -24345431

M S Child Care Clinic | -24345431

M S Child Care Clinic No 4/84, Srinivasa Perumal Sannidhi 1st Street, Royapettah, Chennai – 600014, Behind Safari Hotel | Contact No:- -24345431

[bollywoodirect]

Remembering Motilal, Hindi cinema’s one of the first natural actors, on his 107th birth anniversary today.

Motilal Rajvansh (1910–1965) was an Indian film actor and the winner of Filmfare Best Supporting Actor Award for Devdas (1955) and Parakh (1960).

He also directed the film Chhoti Chhoti Baatein (1965), but died before its release. At the 13th National Film Awards, it won the award for Certificate of Merit for the Third Best Feature Film and he posthumously won the Certificate of Merit for the Best Story Writer.

Born in Shimla on 4 December 1910, Motilal came from a distinguished family from Delhi. His father was a renowned educationist, who died when Motilal was one year old. He was brought up by his uncle who was a well-known civil surgeon in Uttar Pradesh. At first, Moti was sent to an English school at Shimla and later, in Uttar Pradesh (UP). Thereafter, he shifted to Delhi where he continued with school and college.

After leaving college, Moti came to Bombay to join the Navy, but he fell ill and could not appear for the test. Fate had other choices charted out for him. One day, he went to see a film shoot at Sagar Studios, where director K. P. Ghosh was shooting. Motilal, even then, was quite the man about the town and he caught Ghosh's eye. In 1934 (aged 24), he was offered the hero's role in Shaher Ka Jadoo (1934) by the Sagar Film Company. He later featured in several successful social dramas alongside Sabita Devi, including Dr. Madhurika (1935) and Kulvadhu (1937). He worked with Mehboob Khan in Jagirdar (1937) and Hum Tum Aur Woh (1938) under the Sagar Movietone banner, in Taqdeer (1943) for Mehboob Productions, and Kidar Sharma's Armaan (1942) and Kaliyan (1944). He also acted in S. S. Vasan's film Paigham (1959) (Gemini Studios), and Raj Kapoor's Jagte Raho (1956).

In 1965, he also acted in the Bhojpuri film Solaho Singar Kare Dulhaniya.

Perhaps the role for which he received the most critical appreciation was that of the gentleman crook in S. S. Vasan’s adaptation of R K Narayan’s book Mr Sampat (1952). He is most remembered for his role as "Chunni Babu" in Bimal Roy's Devdas (1955), for which he won his first Filmfare Best Supporting Actor Award. Actor Naseeruddin Shah once described him as one of three all time best actors of Hindi cinema, others being Balraj Sahni and Yakub.

Like बॉलीवुड डायरेक्ट Bollywoodirect

[susangkomengreaternyc]

SABCS 2019 Key Takeaways

Komen NYC’s Key Takeaways from the San Antonio Breast Cancer Symposium (SABCS) 2019 December 9-13, 2019 Henry B. Gonzalez Convention Center San Antonio, TX

Our first-day selfie! Yay!!

Patient Advocate extraordinaire, Kelli Davis, and I were thrilled to represent Komen NYC!  SABCS is the yearly mecca for breast cancer researchers, oncologists, surgeons, and radiologists from every corner of the globe.

It could be hard to get to the sessions because of all the people we stopped to chat with.

Stopping to check-out the Male Breast Cancer Coalition’s booth.

Running into Komen Scholar, Steffi Oesterreich, PHD

K. Davis, S. Oesterreich, PhD, N. Stromer, L. Tantawi

Particularly notable this year and totally fantastic? The SLEW of bold and intrepid patient advocates who came to SABCS19 to SLAY. Here is fearless patient advocate, Lianne Kraemer, taking the microphone to advocate for trials to NOT exclude patients with active brain metastases.

Go Lianne!

I would be remiss to not give a shout-out to Eli Lilly for instituting a Patient Advocate Lounge!!! It was conveniently located and provided refreshments and a meet-up place for all the advocates.

Me and Kelli with Komen Scholar and Komen NYC Medical Advisory Committee member extraordinaire, Dawn Hershman, MD, MS. Dr. Hershman gave an eye-opening presentation on the prevalence and risks associated with non-adherence to endocrine therapy. “Therapy doesn’t work if it’s not taken.” Less than 50% of patients take hormone therapy correctly for the full duration prescribed!!

L. Tantawi, K. Davis, D. Hershman, MD, MS

Notable themes throughout the conference? Deescalation of therapy and finding more ways to bring immunotherapy into breast cancer treatment.

Possibly the most exciting, tears of joy, practice-changing presentation? The HER2CLIMB study which was presented by Komen Scholar, Ian Krop, MD, PhD. This study showed reduced risk of progression or death by 46%!!  AND 47% with active brain mets. Since SABCS19 the FDA has granted Breakthrough Therapy Designation to the addition of this study’s drug, tucatinib, to trastuzumab (Herceptin) and capecitabine for patients with locally advanced unresectable or metastatic HER2-positive breast cancer, including those with brain metastases. Exciting news for our HER2-positive MBC friends who have progressed on other lines of treatment.

Kevin Kalinsky, MD, MS, a Komen NYC Medical Advisory Committee Member and amazing Komen NYC friend hit it out of the park discussing immune activity in early-stage vs. metastatic triple-negative breast cancers. Is PD-L1 status the best predictor for checkpoint inhibitor response? Also discussed, the potential for overtreatment with checkpoint inhibitors in the curable subset and the likelihood of long-term, debilitating toxicities. And the importance of “Right patient, right agent, right time.”

Susan G. Komen is funding potential practice-changing research for early-stage aggressive HER2+ disease. Could targeted therapy TDM1 be better than Herceptin plus Taxotere?

Congrats!! Komen NYC friend, the always amazing, Neil Vasan, MD, Ph.D. was selected for a Susan G. Komen Career Catalyst Research Grant. His project: Conquering Metastasis, Exploiting PIK3CA Mutations to Improve PI3K-targeted Therapy for ER+ Metastatic Breast Cancer.

And lastly, look at this!!!!! An oral paclitaxel (Taxol) which = less neuropathy and alopecia. Sounds like a game-changer with regards to patient quality of life!!!

Another SABCS Highlight? The annual Brinker Awards for Scientific Distinction. Read more about the 2019 awardees.

Also notable:

Important Susan G. Komen Funded research presented at SABCS19, INFORM Study: Treatment Options for HER2 Negative patients with BRCA 1/2 mutations.

Important study presented by Komen Scholar, Bryan Schneider, MD,  moves us closer to predicting recurrence and informing the treatment of triple-negative breast cancer.

Want more? Check out Living Beyond Breast Cancer’s interview with Dr. Hope Rugo sharing her key highlights. And for all things SABCS19 and MBC please read Anne Loeser’s, the author of the Insider’s Guide to Metastatic Breast Cancer, summary. And of course, the Komen NYC Twitter feed has all of our live reporting.

Look who we ran into on our last day!! Our friend and Susan G. Komen Chief Scientific Advisor, George Sledge, Jr. MD.

And, last but not least, we picked up some GREAT healthy eating tips and recipe cards from our friends at Athenex Oncology. They are FREE! Order as many as you need!

[evoldir]

Fwd: Postdoc: IGS_UMaryland.BigDataEvolutionaryGenomics

Begin forwarded message: > From: evoldir@evol.biology.mcmaster.ca > Subject: Postdoc: IGS_UMaryland.BigDataEvolutionaryGenomics > Date: 5 September 2019 at 07:28:36 BST > To: rdmpage@gmail.com > > > What our group is looking for: > Are you a collaborative scientist with an interest in working on > large-scale international genomics consortium? Do you have > bioinformatics skills and a desire to expand them? Do you work well > with others and want to enjoy your science while making a cutting edge > impact on the fields of genomics and evolution? We are seeking a > postdoctoral fellow to work on a project funded under the new NHGRI > R35 Genomic Innovator Award recently given to Dr. Tim O”ÆConnor > (https://ift.tt/2MS55eF; http://tiny.cc/TDO_CV). > > What we have: > We are a dynamic group of scientists in the O”ÆConnor Evolutionary > Genetics Group (https://ift.tt/2NX6Nei) and > with key collaborators, we have access to a deluge of genomic data. We > will be leading a number of studies within the Trans-Omics for > Precision Medicine (TOPMed) Project (www.nhlbiwgs.org) to integrate > multi-omics data for deeply phenotyped and ancestrally diverse > individuals. We have already sequenced over 140K genomes and are > generating metabolomics, transcriptomics, and proteomics data for some > of these individuals. We are also working to explore health > disparities in outcomes for cancer patients by combining proteomics > and genomics. > > At the Institute for Genome Sciences at the University of Maryland > School of Medicine (https://ift.tt/2MWwmwq), you will also benefit > from a community of interactive research groups, bioinformatics > programmers, and a variety of sequencing and computational resources > available in a world-class institute dedicated to genomic, basic, and > translational research to improve human health. > > Qualifications: > -PhD with expertise in the areas of Bioinformatics, Evolutionary and > Population Genetics, Computer Science, or related fields. > -Publication record commensurate with experience > -Strong computational and programming skills (Python/R) > -Demonstrated ability to work with others > -Potential to lead your own scientific project > -Experience working with large data sets is preferred > -A desire to learn and have fun > > What we need from you: > Please send a CV (with all papers and pre-prints), a cover letter > detailing your scientific goals for this position (2 pages), and > contact for three references to timothydoconnor@gmail.com > > If you are attending, Dr. O”ÆConnor will be at ASHG in Houston, TX and > would be happy to meet with you and discuss this opportunity further. > Let him know when you contact him. > > Recent Key Pre-prints and Papers from the group: > Taliun, D.*, Harris, D. N.*, Kessler, M. D.*, [...], Hernandez, R. D., > O'Connor, T. D.**, Abecasis, G. R.** Sequencing of 53,831 diverse > genomes from the NHLBI TOPMed Program. > https://ift.tt/2tTYzso > > Harris, D. N., Kessler, M. D., Shetty, A. C., Weeks, D. E., Minster, > R., Browning, S., Cochrane, E. E., Deka, R., Hawley, N. L., Reupena, > M. S., Naseri, T., Trans-Omics for Precision Medicine (TOPMed) > Consortium, TOPMed Population Genetics Working Group, McGarvey, S. T., > O”ÆConnor, T. D. Evolutionary genomics of Samoans. > https://ift.tt/2MVoyep > > Kessler, M. D., Loesch, D. P., Perry, J., Heard-Costa, N. L., Cade, > B., Wang, H., Daya, M., Ziniti, J., Datta, S., CeledØ®n , J. C., > Soto-Quiros, M. E., Avila, L., Weiss, S. T., Barnes, K., Redline, S., > Vasan, R. S., Johnson, A. D., Mathias, R. A., Hernandez, R., Wilson, > J. G., Nickerson, D. A., Abecasis, G., Browning, S., Zoellner, S., > O”ÆConnell, J., Mitchell, B., TOPMed, Consortium, TOPMed Population > Genetics Working Group, O”ÆConnor, T. D. de novo mutations across 1,465 > ancestrally diverse genomes reveal novel mutational insights and > reductions in the Amish founder population. > https://ift.tt/2NX6OPo > > Kessler, M. D., Bateman, N. W., Conrads, T. P., Maxwell, G. L., > Dunning Hotopp, J. C., O”ÆConnor, T. D. (2019) Ancestral > characterization of 1018 cancer cell lines highlights disparities, and > reveals gene expression and mutational differences. Cancer. > 125(12):2076-2088. > https://ift.tt/2MVlLC3 > > Updated Ad can be found here: > https://ift.tt/2NX6Pmq > > > Timothy D. O'Connor, PhD > Assistant Professor > Institute for Genome Sciences and the Department of Medicine > University of Maryland School of Medicine > 670 W. Baltimore Street, Rm. 3181 > Baltimore MD, 21201 > Google Voice:  443-681-9995 > Office: 410-706-6784 > Twitter: @OcOutlier > https://ift.tt/2MW52Pc > > > Timothy O'Connor > via IFTTT

[viz-release-blog]

GOQii Launches Exclusive U.S. Beta

New Post has been published on https://vizrelease.com/press-release/2283079/

GOQii Launches Exclusive U.S. Beta

GOQii Inc., the digital health platform that is dedicated to enabling a permanent shift to a healthier lifestyle, announced today that its exclusive U.S. Beta trial will launch in February. GOQii (“GO-KEY”) is the only company built on the foundation of human-centric, one-on-one health coaching combined with wearables, health apps, big data and Karma.

The GOQii Beta will be limited to 500 participants who will receive 12 months of personalized health coaching to help them with goal setting, habit change, accountability and motivation.

Included in the Beta’s subscription is the GOQii Band activity tracker and app to measure and track sleep, activities, nutrition and Karma Points, GOQii’s gamification system that converts daily goal achievement into real monetary donations for worthy causes. The exclusive one-time price for the full-year Beta is only $99. People can apply to join the Beta beginning on January 22 at GOQii.com.

Research has shown that fitness trackers alone do not make people healthier. GOQii’s integration of actual health coaches differentiates it from existing fitness applications, trackers and online services.

With an inherent focus on personalized mentoring, GOQii coaches will interact individually with every user on a one-on-one basis through the app as they endeavor to attain positive, long-term results through habit changes.

The U.S. GOQii Beta will integrate with other popular health and fitness tracking apps, including Apple’s HealthKit.

“GOQii’s philosophy is driven by our passion for healthy and meaningful living,” explains GOQii Founder and CEO Vishal Gondal. “After using a number of wearables, I felt that something was missing. They lacked sustained engagement, motivation, customized advice and a human connection. I was looking for the complete solution for a more fulfilling way of life. With GOQii we have created that solution.”

The program takes a triple-pronged approach that focuses on the body, mind and soul. Coaches inspire users to maintain proper nutrition, activity levels and exercise, while monitoring the user’s sleep and health habit changes.

Members of the Beta will have the opportunity to select the coach who best suits their personal health and fitness goals.

“GOQii enhances and influences affirmative goal-oriented choices in building a better lifestyle. The best way to reach your potential and achieve your wellness goals is with a coach,” says Gondal.

GOQii Inc. is a digital health platform dedicated to enabling a permanent shift to a healthier lifestyle through a combination of one-on-one health coaching, activity tracking technology and Karma Points, GOQii’s exclusive points system that results in donations to worthy causes. At the heart of the system are the GOQii coaches who are driven by a passion for healthy sustainable living and believe in the boundless potential of their users.

Founded by one of India’s leading tech entrepreneurs, Vishal Gondal, GOQii has generated an overwhelming response during its trial launch in India and resulted in customer validation as well as partnerships with Microsoft, Oxfam International and Reebok.

GOQii is funded by leading angel investors, such as Amit Singhal (Google), Anil Godhwani (Habitera), Bharat Vasan (MyBasis), Marco Argenti (Amazon), Deepak Shahdadpuri (DSGCP), Dr. Shriram Nene, Esther Dyson (EFF), Gautam Godhwani (Simply Hired), Kanwaljit Bombra (Dell), Madhuri Dixit-Nene (Bollywood Actress), Mahesh Samat (Epic), Mike McNamara (Flextronics), Prashant Gulati (TiE), Sanjay Parthasarthy (Indix), Sanjay Vaswani, Steve Luczo (Seagate), Taher Khorakiwala, Vijay Vashee (Microsoft), Rajan Anandan (Google) and S. Somasegar (Microsoft) .

[todaynewsstories]

High blood pressure before age 40 tied to earlier strokes, heart disease

(Reuters Health) – People who develop high blood pressure before age 40 have a higher risk of heart disease and strokes in middle age, two new studies suggest.

One of the studies followed 4,800 young adults in the U.S. and found elevated blood pressure before age 40 associated with up to 3.5 times greater risk of heart disease and strokes over about 19 years of follow-up.

The second study examined data on almost 2.5 million young adults in South Korea over a decade and also found high blood pressure before age 40 was linked to greater risk of heart disease and strokes. Women in this study had up to a 76 percent higher risk of cardiovascular disease, while for men the risk was 85 percent higher, compared to peers with normal blood pressure.

“Elevated blood pressure in early adulthood can result in heart attacks by several mechanisms, and these levels of blood pressure may progress to higher levels over time,” said Ramachandran S. Vasan of the schools of medicine and public health at Boston University.

“They are often associated with . . . other risk factors (such as excess weight, high cholesterol, high blood sugar and smoking) that synergistically elevate heart attack and stroke risk,” Vasan, author of an accompanying editorial, said by email. “They may promote damage to target organs including heart and arteries, thickening of the arterial walls and build up of cholesterol deposits/plaques in arteries, thereby creating a substrate (‘soil’, if you will) for future heart attacks and strokes.”

For the studies, both published in JAMA, researchers assessed high blood pressure using new, more aggressive target levels recommended by the American Heart Association and the American College of Cardiology in 2017. The new recommendations were based on emerging evidence suggesting that even slightly elevated blood pressure early in life might be a precursor to cardiovascular disease as people age.

Patients were classified as having hypertension when the “top number,” or systolic pressure (reflecting the pressure against artery walls when the heart beats), averaged at least 130 mmHG (millimeters of mercury).

They were also considered to have hypertension if the “bottom number,” or diastolic pressure (reflecting pressure against artery walls when the heart rests between beats), averaged at least 80 mmHG.

Before the new recommendations in 2017, people were not diagnosed with high blood pressure until they had measurements of 140/90 mmHG or higher.

Not all doctors have been treating patients using the new, more aggressive blood pressure target, in part out of concern that long-term use of medications to lower blood pressure might have side effects, such as diarrhea or constipation, dizziness, fatigue, headaches, nausea or vomiting or mood disorders.

While young adults with high blood pressure should consider the potential for medication side effects, they may be able to manage their blood pressure with lifestyle changes like eating better or exercising more and they should discuss these options with their doctor, said the senior author of the Korean study, Dr. Sang Min Park of Seoul National University Hospital.

“We have shown that hypertension even at a young age may be associated with higher risk for heart attacks or strokes,” Park said by email. “Therefore, young adults with hypertension should have their blood pressure monitored on a regular basis and manage their blood pressure levels by lifestyle changes or medications.”

Lifestyle changes are not only beneficial in reducing blood pressure and cardiovascular disease risk but could also lead to improved physical and mental health, Park noted.

Neither study looked at whether aggressive blood pressure treatment might stop people from developing heart disease or dying from it.

But the results still suggest that treating blood pressure more aggressively at a younger age might help minimize the risk of premature heart problems later in life, said the U.S.-based study’s lead author Dr. Yuichiro Yano of Duke University in Durham, North Carolina.

“Our study is among the first to report that people younger than age 40 who have elevated blood pressure or hypertension are at increased risk of heart failure, strokes and blood vessel blockages as they age,” Yano said by email.

SOURCE: bit.ly/2PQI24U, bit.ly/2qAZQD9, bit.ly/2PfMNFG and bit.ly/2PPqZjU JAMA, online November 6, 2018.

Our Standards:The Thomson Reuters Trust Principles.

Source link

The post High blood pressure before age 40 tied to earlier strokes, heart disease appeared first on Today News Stories.

from WordPress https://ift.tt/2qzcfXU via IFTTT

[reogenindia]

S S Clinic | No Number!

S S Clinic | No Number!

S S Clinic No 106, West Jones Road, Saidapet, Chennai – 600015, Near Jayaraj Theatre | Contact No:- No Number!

[pkstudiosindia]

Why posters and cut-outs in Tamil cinema are much more than advertisements – The News Minute

Why posters and cut-outs in Tamil cinema are much more than advertisements – The News Minute

In a panel dialogue, individuals talked in regards to the artwork and effort of constructing these posters and what they’ve come to imply in totally different instances.

Artist Jeevananthan, who began out as a banner artist in Tamil cinema, having intently adopted in his father’s footsteps, recollects a 10×10 magnificent banner he helped put collectively on a busy highway in Coimbatore someday throughout the ‘80s. It was a stunning portrait of Rajinikanth’s face carrying darkish shades along with his head tilted up. And mirrored on the sun shades, had been tall timber.

“It was a real sensation on the main road in Coimbatore, a road like Chennai’s Mount Road. People used to stop their vehicles and look towards the opposite direction of the banner to see if there really were trees on the other side of the road. That is my most favourite banner,” Jeevananthan shares. 

The artist was talking at a web based panel dialogue on Saturday, organised by Chennai Photo Biennale titled “Banners, Cutouts and Posters: Tamil Cinema’s Tryst with Visual Art”, moderated by Dr Uma Vangal, Fulbright Scholar and movie professor. Other panelists had been movie historian and writer S Theodore Baskaran, writer and artwork historian Dr Preminda Jacob and cinematographer and filmmaker Rajiv Menon.

The artwork of banner making

Jeevananthan, who says that he was “born with banners”, provided that his father was already portray them since earlier than he was born, additionally spoke in regards to the laborious course of that goes into making a banner or a lower-out for movies, which was among the many highlights of the session. In reality, the banner tradition was born right here in Chennai and unfold to different components of the nation. “SS Vasan’s Chandralekha was a breakthrough in that sense. Just TR Rajakumari’s jimikki (earring) in the banner would be 10 feet high and movie-goers in Mumbai and Calcutta would stare at it in amazement and shock,” Jeevananthan shares.

The ‘gada’ fabric purchased in items is stitched collectively to make for the massive canvas. Wooden items are nailed collectively to make the body. The banner-making studio, that has at the very least 10 to 15 staff together with tailors and carpenters, is now at some extent of excessive exercise. The water coat, a very smelly gum known as ‘vajram’ combined with chalk powder, goes first on the canvas adopted by an oil coat. Barrels of linseed oil are stocked for this goal. Then comes sketching.

Artists made use of magic lantern approach, in which a rudimentary projector forged the photographs from onto the canvas. “Even until the ‘70s and ‘80s, distributors or producers (who commissioned these banners) would give us black and white stills. The stills would be copies, made into negatives that would be mounted on slides to be projected onto the canvas,” Jeevananthan explains.

Artists perched upon makeshift excessive-tables start with broad strokes, then add a contact right here and a flourish there as the total image is accomplished. After it dried and rolled, it’s transported to the theatre the place it’s reassembled with the body. All of this occurs in breakneck velocity, with the artists getting about three days to complete one banner. “You have to remember – the film industry is a very unorganised business. Even a day before the release reels are passed from one hand to another. Different theatres come with different size requirements. So this work definitely requires extraordinary stamina,” he provides.

Cut-outs, a unique ball sport altogether, required artists engaged on wood planks and becoming them collectively in the top like a puzzle. Cut-outs could typically go as much as 60 toes excessive!

The early years

Film historian Theodore Bhaskaran, who has authored books like ‘Eye of the Serpent’ and ‘History through the Lens – Perspectives on South Indian Cinema’ supplied insights into the evolution of show artwork for cinema. “Tamil cinema had 15 years of silent films during which time 124 feature films were made. But not one single document we have from that period,” he stated.

Then in a while, manufacturing homes got here up with modern methods of promoting the movie. “Flash cards were popular in the late 1930 when below the still from the film, there’d be a space to insert details about the cast. In 1942, SS Vasan made posters announcing interesting competitions. These were unique ways of promoting the film,” he stated.

Interestingly, these posters in these days had solely the movie’s actors. “Actors like PU Chinappa, TR Rajakumari were painted big to draw the crowd. The director’s name too started featuring much later. Also, later on, other departments started gaining spots on these posters. You could see Kalaignar’s name on it if he had written dialogues. Then, after a point in time, the film’s music team gained a spot on the poster. It has changed gradually over the years,” he explains. The similar art work was normally repurposed and used in posters and different promotional materials.

Bhaskaran additionally spoke in regards to the significance of songbooks. “These books would have the film’s premise and would end on a cliff-hanger. They would also have the song’s details, the raagam in which it was composed, credits, etc. The last songbook I saw was in 1993 for a film called Tirudathe Tirudathe. It came inside a cassette. The Roja Muthaiah library, we have 2,000 such songbooks. They don’t make them anymore,” he added.

Poster artwork and altering instances

Rajiv Menon, who has labored as cinematographer in movies like Mani Ratnam’s Bombay to creating his personal movies like Minsara Kanavu, Kandukondein Kandukondein and Sarvam Thaala Mayam, spoke in element about what goes into making film posters that condense the entire concept of the movie into one nonetheless imagery, to attraction to the plenty. Referring to a selected Bombay poster, he says, “How does a film like Bombay translate into poster art? There’s the geography of Bombay established by showing the Gateway of India, there’s a scene from the ‘Kuchikuchi Rakkamma’ song to show that there’s love and on the other side there’s a still from the riots. This is how it comes together.” 

“The visual imagery which is a shorthand condensing and compacting an image and the whole visual medium comes down to one icon,” he added. Pointing out that stills of songs had been an necessary side of posters, Rajiv stated, “Costumes in songs are solely designed for featuring on posters. Increasingly, representation of film songs on Indian film posters is reducing. Our posters are looking more and more western. We are losing out on uniquely Indian and great artists like Jeevananthan. Our visual culture is getting closer to the international cinema but we are also losing the uniqueness.”

An unexplainable fascination

Dr Preminda Jacob, who has authored ‘Celluloid Deity’ spoke about how she rediscovered banner artwork after having moved to the US for her research. “I called my brother to send me photographs from the streets in Chennai and I was amazed to know how I failed to notice them during my growing up years there!” she says.

Going on to speak in regards to the impression these massive hoardings had on cinema followers, she explains, “The intensity of response that banners and cut-outs generated speaks to the power of celebrity. The thrills of entertainment and the pride of being part of a cosmopolitan modernity. In this sense, they exceeded their function as advertisement and became a focal point for fans to come together as a community and celebrate their star and the phenomenon of entertainment cinema.”

“The convalescence of cinema and politics that has shaped the modern history of Tamil Nadu was enabled through the visual art of banners and cut-outs. The medium produced images for film stars and politicians that towered over the city,” she provides.

“To help explain their fascination, this art form combines people’s affective response to three powerful mediums – cinema, photographs and paintings,” she concludes.

The full session is accessible to stream right here: 

The post Why posters and cut-outs in Tamil cinema are much more than advertisements – The News Minute appeared first on Pet Food India.

from WordPress https://petfoodindia.com/why-posters-and-cut-outs-in-tamil-cinema-are-much-more-than-advertisements-the-news-minute/

[vipulsharma17]

Introduction Of Indian Cinema

Some memorable films in were produced during the forties such as Shantaram's Dr. Kotnis Ki Amar Kahani, Mehboob's Roti, Chetan Anand's Neecha Nagar, Uday Shankar's Kalpana, Abbas' Dharti Ke Lal, Sohrab Modi's Sikandar, Pukar and Prithvi Vallabh, J.B.H. Wadia Court Dancer, S.S. Vasan's Chndralekha, Vijay Bhatt's Bharat Milap and Ram Rajya, Raj Kapoor's Barsaat and Aag. The first International Film Festival of India held in early 1952 at Bombay had great impact of Indian Cinema. The big turning point came in 1955 with the arrival of Satyajit Ray and his classic Pather Panchali which opened up a new path leading the Indian film to the world film scenario. In Hindi Cinema too, the impact of neorealism was evident in some distinguished films like Bimal Roy' Do Bigha Zamin, Devdas and Madhumati, Raj Kapoor's Boot Polish and Shree 420 and Jagte Raho, V. Shantaram's Do Aankhein Barah Haath and Jhanak Jhanak Payal Baaje, Mehboob Khan's Mother India, Guru Dutt's Pyasa and Kagaz Ke Phool and B.R. Chopra's Kanoon. The first Indo- Soviet Co-production Pardesi by K.A. Abbas was also made during the fifties. The sixties was a decade of mediocre films made mostly to please the distributors and to some extent, meet the demands of the box office. The sixties began with a bang with the of K. Asif 's Mughal-e-Azam which set a record at the box office. It was followed by notable production which includes musical and melodramas of a better quality. Raj Kapoor's Jis Desh Main Ganga Behti Hai, Sangam, Dilip Kumar's Ganga Jamna, Guru Dutt's Sahib Bibi Aur Gulam, Dev Anand's Guide; Bimal Roy;s Bandani, S.Mukherjee's Junglee, Sunil Dutt's Mujhe Jeene Do, and the experimental Yadein, Basu Bhattacharya's Teesri Kasam, Pramod Chakravarty 's Love In Tokyo, Ramanand Sagar Arzoo, Sakti Samanta's Aradhana, Hrishikesh Mukherjee's Arshiwad and Anand, B.R. Chopra Waqt, Manoj Kumar's Upkar, and Prasad Production Milan were the significant Hindi Films of the decade. The seventies has further-widened the gap between multi-star big budgeted offbeat films. The popular Hindi hits of the decade include Kamal Amrohis Prakeezah, Raj Kapoor's Bobby, Devar's Haathi Mere Saathi, Ramesh Sippy's Sholay and many more of the seventies were action-oriented with revenge as the dominating theme. Many memorable movies produced in a next two decades like; Mashaal, Aakrosh, Silsila, Shakti, Chandni, Karma, Parinda, Lekin, Qayamat Se Qayamat Tak, Maine Pyar Kiya, Diwaana, Darr, Bazigar, DDLJ, Jo Jeeta Wohi Sikandar, Hum Aapke Hai Kon, Dil Toh Pagal Hai, Kuch Kuch Hota Hai, Lagaan. Of this film turns concept of Indian Cinema.

[big--news]

MES Launches YO® Home Sperm Test in India

First FDA approved device to determine moving sperm (a key to male fertility)

Test your sperm from the comfort of your home using smartphone video technology

Gives 97% accurate results

Pune,  April 26, 2018: Medical Electronic Systems (MES), a Los Angeles based technology company specializing in rapid Automated Semen Analysis, today announced the launch of YO® Home Sperm Test in India, a first-of-its kind video-based smartphone platform that is FDA-cleared to measure Motile Sperm Concentration (the number of moving sperm) which is a critical factor in determining male fertility. With 97% accuracy, YO® provides consumers the ability to both view and measure the number of motile (moving) sperm in their sample on their phone and from the comfort of their home and make male fertility testing an easy process.

India is experiencing a decline in fertility due to a variety of reasons such as poor lifestyle habits (smoking, overheating), pollution, age (postponing conception). Traditionally, concerns about fertility have focused primarily on women’s fertility issues. However, there is a growing awareness that men’s reproductive health issues also contribute to infertility.

The cause of infertility is equally shared by men and women. Approximately 40% of the problem is a female factor and 40% a male factor with the remaining 20% unexplained or a combined problem between the man and the woman. Yet, many times, the initial focus of a fertility assessment is on the woman and the man may not be tested until a full female work-up and treatment is unsuccessful, which could take a year or more.  This delay in testing the male side of an infertile couple, plus the fact that couples are postponing having children until their 30’s places the couple at greater risk of being childless and substantially increases their anxiety about conceiving.

In order to address the problem of delayed male testing and to eliminate the stressful public nature of male sperm analysis, the YO® Home Sperm Test kit was developed by Medical Electronic Systems. “YO® is both an accurate and private home test that provides a precise assessment of moving sperm concentration (MSC). Testing moving sperm is critical in a home test because, with a clear video to back it up, the results allow the man to approach the doctor with clear evidence of a problem. I see YO as a game changer in India and globally because of the profound need for a test of this type as a first step in the process of diagnosing male factor infertility in a timely basis,” said Dr. Vasan, a leading Uro-Andrologist in India is Chairman of Manipal Fertility, President-Elect of the South Asian Society for Sexual Medicine (SASSM) and has recently been appointed Secretary General of the Asian Society for Female Urology.  

“We believe that there is a profound need for a device like YO® in India and we urge the medical fraternity to extend their support so that the product is made available to as many couples as possible in order to make their journey to parenthood a reality,” added Dr. Vasan.

The FDA and CE cleared YO® Home Sperm Test kit is sold online through the YO website www.yospermtest.com or through AMAZON. It is delivered in a plain box for confidentiality. The simple, step-by-step app is downloaded free of charge from Google Play or the App Store. The YO Clip (a mini-microscope) is supplied in the kit with all the supplies required to run two tests on your Smartphone. The app is easy to follow and takes the user through step-by-step interactive screens and instructional animations to insure a smooth, easy-to-understand and secure testing experience with accurate results. There is also humor built into the Sperm Trivia Challenge, which is designed to interact with the user during the sample preparation wait time. YO® Home Sperm Test results are reported within minutes along with a video of the sperm. This provides both instant test results requiring no interpretation and a “wow” factor when the tester sees his sperm in action.

Since it takes a moving sperm to fertilize an egg in normal conception, assessing moving sperm concentration, like YO does, is critical for indicating male fertility potential. There are other factors such as abnormally shaped sperm or a low overall number of sperm that also impact male fertility so walking into your doctor’s office with an accurate assessment of moving sperm and your own sperm video, will substantially reduce the stress of facing additional testing when you already know you have a problem. With YO® Home Sperm Test, men can test themselves at home and receive 97% accurate and fast results very quickly.  

YO® Home Sperm Test kit is available on the YO® website and on Amazon India for INR 1990.  The kit contains supplies for two tests. Plans are already in place by MES for YO to individually track your sperm results over time and give you a YO SCORE result. This can help to assess the success of lifestyle changes made to improve your sperm quality.

Watch  a video of how YO® works at: https://www.youtube.com/watch?v=ddYpR2swBtY&t=5s

About MES:

Medical Electronic Systems, the company behind the YO® Home Sperm Test, has been producing and supplying commercial-grade automated semen analyzers to the global market for over 15 years. Thousands of the company’s Sperm Quality Analyzers (SQA) are installed in hospitals and independent laboratories globally, including research labs, premier hospital systems, fertility clinics and centers of reproductive excellence across the world. Medical Electronic System’s (www.mes-global.com) automated semen analyzers are known and trusted as the premier automated solution in the industry because they perform reliably and accurately on a routine basis, thereby making MES one of the largest purveyor of automated semen analyzers globally.

[varansai-varta]

MES Launches YO® Home Sperm Test in India

First FDA approved device to determine moving sperm (a key to male fertility)

Test your sperm from the comfort of your home using smartphone video technology

Gives 97% accurate results

Pune,  April 26, 2018: Medical Electronic Systems (MES), a Los Angeles based technology company specializing in rapid Automated Semen Analysis, today announced the launch of YO® Home Sperm Test in India, a first-of-its kind video-based smartphone platform that is FDA-cleared to measure Motile Sperm Concentration (the number of moving sperm) which is a critical factor in determining male fertility. With 97% accuracy, YO® provides consumers the ability to both view and measure the number of motile (moving) sperm in their sample on their phone and from the comfort of their home and make male fertility testing an easy process.

India is experiencing a decline in fertility due to a variety of reasons such as poor lifestyle habits (smoking, overheating), pollution, age (postponing conception). Traditionally, concerns about fertility have focused primarily on women’s fertility issues. However, there is a growing awareness that men’s reproductive health issues also contribute to infertility.

The cause of infertility is equally shared by men and women. Approximately 40% of the problem is a female factor and 40% a male factor with the remaining 20% unexplained or a combined problem between the man and the woman. Yet, many times, the initial focus of a fertility assessment is on the woman and the man may not be tested until a full female work-up and treatment is unsuccessful, which could take a year or more.  This delay in testing the male side of an infertile couple, plus the fact that couples are postponing having children until their 30’s places the couple at greater risk of being childless and substantially increases their anxiety about conceiving.

In order to address the problem of delayed male testing and to eliminate the stressful public nature of male sperm analysis, the YO® Home Sperm Test kit was developed by Medical Electronic Systems. “YO® is both an accurate and private home test that provides a precise assessment of moving sperm concentration (MSC). Testing moving sperm is critical in a home test because, with a clear video to back it up, the results allow the man to approach the doctor with clear evidence of a problem. I see YO as a game changer in India and globally because of the profound need for a test of this type as a first step in the process of diagnosing male factor infertility in a timely basis,” said Dr. Vasan, a leading Uro-Andrologist in India is Chairman of Manipal Fertility, President-Elect of the South Asian Society for Sexual Medicine (SASSM) and has recently been appointed Secretary General of the Asian Society for Female Urology.  

“We believe that there is a profound need for a device like YO® in India and we urge the medical fraternity to extend their support so that the product is made available to as many couples as possible in order to make their journey to parenthood a reality,” added Dr. Vasan.

The FDA and CE cleared YO® Home Sperm Test kit is sold online through the YO website www.yospermtest.com or through AMAZON. It is delivered in a plain box for confidentiality. The simple, step-by-step app is downloaded free of charge from Google Play or the App Store. The YO Clip (a mini-microscope) is supplied in the kit with all the supplies required to run two tests on your Smartphone. The app is easy to follow and takes the user through step-by-step interactive screens and instructional animations to insure a smooth, easy-to-understand and secure testing experience with accurate results. There is also humor built into the Sperm Trivia Challenge, which is designed to interact with the user during the sample preparation wait time. YO® Home Sperm Test results are reported within minutes along with a video of the sperm. This provides both instant test results requiring no interpretation and a “wow” factor when the tester sees his sperm in action.

Since it takes a moving sperm to fertilize an egg in normal conception, assessing moving sperm concentration, like YO does, is critical for indicating male fertility potential. There are other factors such as abnormally shaped sperm or a low overall number of sperm that also impact male fertility so walking into your doctor’s office with an accurate assessment of moving sperm and your own sperm video, will substantially reduce the stress of facing additional testing when you already know you have a problem. With YO® Home Sperm Test, men can test themselves at home and receive 97% accurate and fast results very quickly.  

YO® Home Sperm Test kit is available on the YO® website and on Amazon India for INR 1990.  The kit contains supplies for two tests. Plans are already in place by MES for YO to individually track your sperm results over time and give you a YO SCORE result. This can help to assess the success of lifestyle changes made to improve your sperm quality.

Watch  a video of how YO® works at: https://www.youtube.com/watch?v=ddYpR2swBtY&t=5s

About MES:

Medical Electronic Systems, the company behind the YO® Home Sperm Test, has been producing and supplying commercial-grade automated semen analyzers to the global market for over 15 years. Thousands of the company’s Sperm Quality Analyzers (SQA) are installed in hospitals and independent laboratories globally, including research labs, premier hospital systems, fertility clinics and centers of reproductive excellence across the world. Medical Electronic System’s (www.mes-global.com) automated semen analyzers are known and trusted as the premier automated solution in the industry because they perform reliably and accurately on a routine basis, thereby making MES one of the largest purveyor of automated semen analyzers globally.

[srinagar-varta]

MES Launches YO® Home Sperm Test in India

First FDA approved device to determine moving sperm (a key to male fertility)

Test your sperm from the comfort of your home using smartphone video technology

Gives 97% accurate results

Pune,  April 26, 2018: Medical Electronic Systems (MES), a Los Angeles based technology company specializing in rapid Automated Semen Analysis, today announced the launch of YO® Home Sperm Test in India, a first-of-its kind video-based smartphone platform that is FDA-cleared to measure Motile Sperm Concentration (the number of moving sperm) which is a critical factor in determining male fertility. With 97% accuracy, YO® provides consumers the ability to both view and measure the number of motile (moving) sperm in their sample on their phone and from the comfort of their home and make male fertility testing an easy process.

India is experiencing a decline in fertility due to a variety of reasons such as poor lifestyle habits (smoking, overheating), pollution, age (postponing conception). Traditionally, concerns about fertility have focused primarily on women's fertility issues. However, there is a growing awareness that men's reproductive health issues also contribute to infertility.

The cause of infertility is equally shared by men and women. Approximately 40% of the problem is a female factor and 40% a male factor with the remaining 20% unexplained or a combined problem between the man and the woman. Yet, many times, the initial focus of a fertility assessment is on the woman and the man may not be tested until a full female work-up and treatment is unsuccessful, which could take a year or more.  This delay in testing the male side of an infertile couple, plus the fact that couples are postponing having children until their 30's places the couple at greater risk of being childless and substantially increases their anxiety about conceiving.

In order to address the problem of delayed male testing and to eliminate the stressful public nature of male sperm analysis, the YO® Home Sperm Test kit was developed by Medical Electronic Systems. “YO® is both an accurate and private home test that provides a precise assessment of moving sperm concentration (MSC). Testing moving sperm is critical in a home test because, with a clear video to back it up, the results allow the man to approach the doctor with clear evidence of a problem. I see YO as a game changer in India and globally because of the profound need for a test of this type as a first step in the process of diagnosing male factor infertility in a timely basis,” said Dr. Vasan, a leading Uro-Andrologist in India is Chairman of Manipal Fertility, President-Elect of the South Asian Society for Sexual Medicine (SASSM) and has recently been appointed Secretary General of the Asian Society for Female Urology.  

“We believe that there is a profound need for a device like YO® in India and we urge the medical fraternity to extend their support so that the product is made available to as many couples as possible in order to make their journey to parenthood a reality,” added Dr. Vasan.

The FDA and CE cleared YO® Home Sperm Test kit is sold online through the YO website www.yospermtest.com or through AMAZON. It is delivered in a plain box for confidentiality. The simple, step-by-step app is downloaded free of charge from Google Play or the App Store. The YO Clip (a mini-microscope) is supplied in the kit with all the supplies required to run two tests on your Smartphone. The app is easy to follow and takes the user through step-by-step interactive screens and instructional animations to insure a smooth, easy-to-understand and secure testing experience with accurate results. There is also humor built into the Sperm Trivia Challenge, which is designed to interact with the user during the sample preparation wait time. YO® Home Sperm Test results are reported within minutes along with a video of the sperm. This provides both instant test results requiring no interpretation and a "wow" factor when the tester sees his sperm in action.

Since it takes a moving sperm to fertilize an egg in normal conception, assessing moving sperm concentration, like YO does, is critical for indicating male fertility potential. There are other factors such as abnormally shaped sperm or a low overall number of sperm that also impact male fertility so walking into your doctor’s office with an accurate assessment of moving sperm and your own sperm video, will substantially reduce the stress of facing additional testing when you already know you have a problem. With YO® Home Sperm Test, men can test themselves at home and receive 97% accurate and fast results very quickly.  

YO® Home Sperm Test kit is available on the YO® website and on Amazon India for INR 1990.  The kit contains supplies for two tests. Plans are already in place by MES for YO to individually track your sperm results over time and give you a YO SCORE result. This can help to assess the success of lifestyle changes made to improve your sperm quality.

Watch  a video of how YO® works at: https://www.youtube.com/watch?v=ddYpR2swBtY&t=5s

About MES:

Medical Electronic Systems, the company behind the YO® Home Sperm Test, has been producing and supplying commercial-grade automated semen analyzers to the global market for over 15 years. Thousands of the company’s Sperm Quality Analyzers (SQA) are installed in hospitals and independent laboratories globally, including research labs, premier hospital systems, fertility clinics and centers of reproductive excellence across the world. Medical Electronic System’s (www.mes-global.com) automated semen analyzers are known and trusted as the premier automated solution in the industry because they perform reliably and accurately on a routine basis, thereby making MES one of the largest purveyor of automated semen analyzers globally.

[udaipur-patrika]

MES Launches YO® Home Sperm Test in India

First FDA approved device to determine moving sperm (a key to male fertility)

Test your sperm from the comfort of your home using smartphone video technology

Gives 97% accurate results

Pune,  April 26, 2018: Medical Electronic Systems (MES), a Los Angeles based technology company specializing in rapid Automated Semen Analysis, today announced the launch of YO® Home Sperm Test in India, a first-of-its kind video-based smartphone platform that is FDA-cleared to measure Motile Sperm Concentration (the number of moving sperm) which is a critical factor in determining male fertility. With 97% accuracy, YO® provides consumers the ability to both view and measure the number of motile (moving) sperm in their sample on their phone and from the comfort of their home and make male fertility testing an easy process.

India is experiencing a decline in fertility due to a variety of reasons such as poor lifestyle habits (smoking, overheating), pollution, age (postponing conception). Traditionally, concerns about fertility have focused primarily on women’s fertility issues. However, there is a growing awareness that men’s reproductive health issues also contribute to infertility.

The cause of infertility is equally shared by men and women. Approximately 40% of the problem is a female factor and 40% a male factor with the remaining 20% unexplained or a combined problem between the man and the woman. Yet, many times, the initial focus of a fertility assessment is on the woman and the man may not be tested until a full female work-up and treatment is unsuccessful, which could take a year or more.  This delay in testing the male side of an infertile couple, plus the fact that couples are postponing having children until their 30’s places the couple at greater risk of being childless and substantially increases their anxiety about conceiving.

In order to address the problem of delayed male testing and to eliminate the stressful public nature of male sperm analysis, the YO® Home Sperm Test kit was developed by Medical Electronic Systems. “YO® is both an accurate and private home test that provides a precise assessment of moving sperm concentration (MSC). Testing moving sperm is critical in a home test because, with a clear video to back it up, the results allow the man to approach the doctor with clear evidence of a problem. I see YO as a game changer in India and globally because of the profound need for a test of this type as a first step in the process of diagnosing male factor infertility in a timely basis,” said Dr. Vasan, a leading Uro-Andrologist in India is Chairman of Manipal Fertility, President-Elect of the South Asian Society for Sexual Medicine (SASSM) and has recently been appointed Secretary General of the Asian Society for Female Urology.  

“We believe that there is a profound need for a device like YO® in India and we urge the medical fraternity to extend their support so that the product is made available to as many couples as possible in order to make their journey to parenthood a reality,” added Dr. Vasan.

The FDA and CE cleared YO® Home Sperm Test kit is sold online through the YO website www.yospermtest.com or through AMAZON. It is delivered in a plain box for confidentiality. The simple, step-by-step app is downloaded free of charge from Google Play or the App Store. The YO Clip (a mini-microscope) is supplied in the kit with all the supplies required to run two tests on your Smartphone. The app is easy to follow and takes the user through step-by-step interactive screens and instructional animations to insure a smooth, easy-to-understand and secure testing experience with accurate results. There is also humor built into the Sperm Trivia Challenge, which is designed to interact with the user during the sample preparation wait time. YO® Home Sperm Test results are reported within minutes along with a video of the sperm. This provides both instant test results requiring no interpretation and a “wow” factor when the tester sees his sperm in action.

Since it takes a moving sperm to fertilize an egg in normal conception, assessing moving sperm concentration, like YO does, is critical for indicating male fertility potential. There are other factors such as abnormally shaped sperm or a low overall number of sperm that also impact male fertility so walking into your doctor’s office with an accurate assessment of moving sperm and your own sperm video, will substantially reduce the stress of facing additional testing when you already know you have a problem. With YO® Home Sperm Test, men can test themselves at home and receive 97% accurate and fast results very quickly.  

YO® Home Sperm Test kit is available on the YO® website and on Amazon India for INR 1990.  The kit contains supplies for two tests. Plans are already in place by MES for YO to individually track your sperm results over time and give you a YO SCORE result. This can help to assess the success of lifestyle changes made to improve your sperm quality.

Watch  a video of how YO® works at: https://www.youtube.com/watch?v=ddYpR2swBtY&t=5s

About MES:

Medical Electronic Systems, the company behind the YO® Home Sperm Test, has been producing and supplying commercial-grade automated semen analyzers to the global market for over 15 years. Thousands of the company’s Sperm Quality Analyzers (SQA) are installed in hospitals and independent laboratories globally, including research labs, premier hospital systems, fertility clinics and centers of reproductive excellence across the world. Medical Electronic System’s (www.mes-global.com) automated semen analyzers are known and trusted as the premier automated solution in the industry because they perform reliably and accurately on a routine basis, thereby making MES one of the largest purveyor of automated semen analyzers globally.